"We look forward to our continued collaboration with Alverno, providing its team of expert pathologists with the most advanced AI-powered solutions and supporting diverse patient communities across rural, suburban and large-metro populations," said Justin McCarthy, Head of U.S. sales at Ibex Medical Analytics. "With over 100,000 new cancer cases expected in the Midwest region in 20236, Ibex is committed to advancing the implementation of AI in pathology to support the growing demand for quality diagnostics."
About Alverno Laboratories
Ad Statistics
Times Displayed: 19090
Times Visited: 362 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Alverno Laboratories, located in Hammond, IN, provides clinical and anatomic pathology services and testing to communities throughout Illinois and Indiana. Alverno's focus is providing the best patient care utilizing advanced technologies such as digital pathology, AI, Precision Medicine/Next-Gen Sequencing, and complex automation. As a joint venture between Franciscan Alliance and Ascension Illinois, Alverno Laboratories operates 31 hospital laboratories and provides laboratory testing to over 2,500 physician offices, free standing urgent care facilities, and research organizations. Innovation is at the center of laboratory operations as demonstrated by the acquisition of one of the largest digital pathology networks in the country. Digital pathology, coupled with artificial intelligence technology, will decrease turnaround times of oncology cases and enhance outcomes. Advanced automation in microbiology rapidly increases the diagnosis of bloodborne infections that can lead to Sepsis. For additional company information, please visit https://alvernolabs.com/ and follow us on LinkedIn.
About Ibex Medical Analytics
Ibex Medical Analytics is transforming cancer diagnostics with world-leading clinical grade AI-powered solutions for pathology. Empowering physicians and supporting pathologists, Ibex is on a mission to provide accurate, timely and personalized cancer diagnosis for every patient. Ibex's Galen™ is the first and most widely deployed AI-powered platform in pathology. Pathologists worldwide use Galen™ as part of their everyday routine to improve the accuracy of cancer diagnosis, implement comprehensive quality control measures, reduce turnaround times and boost productivity with more efficient workflows. For additional company information, please visit https://ibex-ai.com/and follow us on LinkedIn and Twitter.
Back to HCB News
